A case of metastatic treatment‐emergent small cell/neuroendocrine prostate cancer with BRCA2 mutation diagnosed by liver biopsy

INTRODUCTION: Treatment‐emergent small cell/neuroendocrine prostate cancer occurs predominantly in advanced or metastatic castration‐resistant prostate cancer that arises when prostate adenocarcinoma is transformed after androgen deprivation therapy. The clinical course for the pathogenesis involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Naiki, Taku, Naiki‐Ito, Aya, Kawai, Tatsuya, Komatsu, Hirokazu, Nishikawa, Ryutaro, Gonda, Masakazu, Aoki, Maria, Sugiyama, Yosuke, Tasaki, Yoshihiko, Yasui, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626340/
https://www.ncbi.nlm.nih.gov/pubmed/36341200
http://dx.doi.org/10.1002/iju5.12501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626340/
https://www.ncbi.nlm.nih.gov/pubmed/36341200
http://dx.doi.org/10.1002/iju5.12501

Ejemplares similares